A detailed history of Kimelman & Baird, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Kimelman & Baird, LLC holds 10,396 shares of JNJ stock, worth $1.62 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
10,396
Previous 9,800 6.08%
Holding current value
$1.62 Million
Previous $1.61 Million 94043.74%
% of portfolio
0.13%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

BUY
$144.38 - $157.78 $86,050 - $94,036
596 Added 6.08%
10,396 $1.52 Billion
Q2 2021

Aug 17, 2021

SELL
$159.48 - $171.07 $15,947 - $17,107
-100 Reduced 1.01%
9,800 $1.61 Million
Q3 2019

Dec 10, 2019

SELL
$126.95 - $142.14 $409,413 - $458,401
-3,225 Reduced 24.57%
9,900 $1.28 Million
Q2 2019

Nov 22, 2019

BUY
$131.15 - $144.24 $1.72 Million - $1.89 Million
13,125 New
13,125 $1.83 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Kimelman & Baird, LLC Portfolio

Follow Kimelman & Baird, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kimelman & Baird, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kimelman & Baird, LLC with notifications on news.